Need professional-grade analysis? Visit stockanalysis.com
$54.85M
N/A
N/A
N/A
RenovoRx Inc (RNXT) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.95, down 0.09% from the previous close.
Over the past year, RNXT has traded between a low of $0.73 and a high of $1.42. The stock has lost 6.1% over this period. It is currently 33.2% below its 52-week high.
RenovoRx Inc has a market capitalization of $54.85M.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.
Side-by-side comparison against top Healthcare peers.